Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1999
11/16/1999US5986065 Antibodies for inhibiting blood coagulation and methods of use thereof
11/16/1999US5986064 Antibodies which specifically bind to human tumor-associated Kazal inhibitor-like polypeptide
11/16/1999US5986061 Phosphorylated fusion proteins
11/16/1999US5986060 Polypeptide with amino acid sequences
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5986057 Amino acid sequences
11/16/1999US5986056 Chordin compositions
11/16/1999US5986055 CDK2 interactions
11/16/1999US5986054 Genetic sequences and proteins related to alzheimer's disease
11/16/1999US5986053 Peptide nucleic acids complexes of two peptide nucleic acid strands and one nucleic acid strand
11/16/1999US5986052 Fusion polypeptide containing fragments of cartilage matrix protein and link protein
11/16/1999US5986051 Genes of Helicobacter pylori necessary for the regulation and maturation of urease and their use
11/16/1999US5986049 Purification by applying a biological fluid to polypeptide support,washing, elution, fractionation and accumulation
11/16/1999US5986048 Process for obtaining insulin precursors having correctly bonded cystine bridges
11/16/1999US5985930 Treatment of neurodegenerative conditions with nimesulide
11/16/1999US5985926 Method for inhibiting intracellular viral replication
11/16/1999US5985846 Gene therapy for muscular dystrophy
11/16/1999US5985832 Inhibiting osteoclastogenesis by administering osteoclast inhibitor protein (oip) to a cell
11/16/1999US5985831 Methods for controlling lepidopterans using Bacillus thuringiensis toxins obtainable from isolates PS17, PS86Q3, and HD511
11/16/1999US5985828 Screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies
11/16/1999US5985668 A dna sequence coding for a protein with a sucrose isomerase activity wherein sucrose is isomerized to palatinose and/or trehalose wherein the cell displays a reduced sucrose metabolism; genetic engineering
11/16/1999US5985666 Forages
11/16/1999US5985664 Antisense modulation of Sentrin expression
11/16/1999US5985663 Antisense inhibition of interleukin-15 expression
11/16/1999US5985662 By incubating hepatitis b virus or incubating cells, tissues, or a bodily fluid which contains hepatitis b virus with an antisense oligonucleotide of given nucleotide sequences under conditions where viral replication is inhibited
11/16/1999US5985661 Human t-lymphocyte transduced in vitro with a vector comprising genes encoding first and second ribozyme moieties, hte first cleaves hiv-1 rna in the tat gene, and second cleaves hiv-1 rna in a common exon for tat and rev genes
11/16/1999US5985657 Nucleotide sequence coding for human il-1; expression vectors and host cells
11/16/1999US5985655 Retroviral vector particle containing a chimeric envelope includes a receptor binding region that binds to a receptor of a target cell; a portion of the envelope gene deleted and replaced with another receptor binding region or ligand
11/16/1999US5985654 Gene which expresses a protein corresponding to the conserved exposed region of the m6 protein, a virulence factor of streptococcus; poxvirus such as vaccinia containing m6 gene used as vaccines against streptococcal infection
11/16/1999US5985650 Enhancing the rate of desulfurization of fossil fuels by the addition of a flavoprotein to the biocatalyst; contacting the fossil fuel with an aqueous phase containing the biocatalyst and flavoprotein, later separating reduced sulfur fuel
11/16/1999US5985647 An isolated resveratrol synthase gene obtained from ground nut (arachis hypogaea) or a synthetic dna sequence encoding the amino acid sequence of resveratrol synthase encoded by the isolated resveratrol synthase gene; pest resistance
11/16/1999US5985646 Thermostable isolated polynucleotide encoding an enzyme wtih amidase activity; an enzyme having activity in the removal of arginine, phenylalanine or methionine from the n-terminal end of peptides in peptide or peptidomimetic synthesis
11/16/1999US5985644 Polynucleotide sequence which encodes endo-i polypeptide, a periplasmic chitodextrinase which hydrolyzes soluble chitin oligosaccharides to produce n-acetylglucosamine dimers and trimers; for efficient production
11/16/1999US5985642 Culturing primary chicken embryonic fibroblasts, passaging until senescence, concentrating to maintain confluence, isolating non-senescent cells, culturing for greater than 30 passages, introducing recombinant virus, isolating virus
11/16/1999US5985641 Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies
11/16/1999US5985640 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
11/16/1999US5985639 Mutant proteolytic enzymes and method of production
11/16/1999US5985637 Gene encoding endo-β-N-acetylglucosaminidase A
11/16/1999US5985635 Nucleic acids encoding novel human serine/threonine protein kinases
11/16/1999US5985634 Chloroplast activity
11/16/1999US5985633 Human manganese superoxide dismutase proteins
11/16/1999US5985631 Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
11/16/1999US5985630 Incubating mixture of metal compound, adenosine triphosphate, synthetase enzyme, rna, an amino acid and an pyrophosphate; measuring phosphate compound produced
11/16/1999US5985626 Schiff base
11/16/1999US5985623 Pure culture of sphingomonas microorganism
11/16/1999US5985622 Reacting sucrose with isomerase protein
11/16/1999US5985621 Capable of cleaving a rna
11/16/1999US5985620 Polynucleotide
11/16/1999US5985617 Microorganisms and methods for overproduction of DAHP by cloned PPS gene
11/16/1999US5985615 Directed switch-mediated DNA recombination
11/16/1999US5985614 Polynucleotides encoding interleukin-19
11/16/1999US5985613 Use of an "immunodeficiency-virus suppressing lymphokine (ISL) "to inhibit the replication of viruses, in particular of retroviruses
11/16/1999US5985611 Culturing animal cells; transformation with gene expression; recovering
11/16/1999US5985610 Gene expression in host cell of conformational epitopes
11/16/1999US5985609 Process for preparing hepatitis C virus envelope glycoproteins
11/16/1999US5985607 Gene expression control sequence
11/16/1999US5985606 Human preprotachykinin B
11/16/1999US5985605 DNA sequences encoding phytases of ruminal microorganisms
11/16/1999US5985604 Polynucleotide
11/16/1999US5985603 P2x receptor DNA and protein sequence
11/16/1999US5985602 Secreted proteins and polynucleotides encoding them
11/16/1999US5985601 Isolated polynucleotide
11/16/1999US5985600 Nucleic acid encoding delta opioid receptor
11/16/1999US5985599 Nucleic acid encoding a protein capable of binding to immunoglobulin
11/16/1999US5985597 DNA encoding prostaglandin receptor EP1
11/16/1999US5985592 Uses for pentoxifylline or functional derivatives/metabolites thereof
11/16/1999US5985590 Expression of Carcinoscorpius rotundicauda Factor C in eukaryotes
11/16/1999US5985589 Dna sequences
11/16/1999US5985588 Phagemid for antibody screening
11/16/1999US5985586 Methods for identifying compounds that modulate the activity of human N-methyl-D-aspartate receptors
11/16/1999US5985585 Competitive binding; detection
11/16/1999US5985583 Hybridization; measurement signal transduction
11/16/1999US5985580 Antibodies which specifically bind to the thymokine lymphotactin
11/16/1999US5985577 Detection od polypeptide segment in living cells
11/16/1999US5985575 Forming fusion protein; binding to reporter rna; calibration
11/16/1999US5985573 Cationic polyacrylates and poly(alkyl) acrylates or the corresponding acrylamides for use in synthetic transfection or blocking systems
11/16/1999US5985572 Quaternary amine surfactant and methods of using same in isolation of RNA
11/16/1999US5985570 Dna fragment isolated from aspergillus; genetic engineering
11/16/1999US5985564 Inhibitor of chromosome segregation
11/16/1999US5985563 Detection of Ribosomal RNA using PNA probes
11/16/1999US5985560 Insertion plasmid into dna
11/16/1999US5985558 Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos
11/16/1999US5985557 Target nucleic acid and oligonucleotide mixture
11/16/1999US5985555 Method and apparatus for processing nucleic acids using a small temperature-changing zone
11/16/1999US5985554 Method of probing the function of proteins or peptides encoded by partially sequenced cDNAs by inhibiting protein synthesis with antisense oligonucleotides
11/16/1999US5985552 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
11/16/1999US5985551 Method and apparatus for conducting an array of chemical reactions on a support surface
11/16/1999US5985550 Double receptor polynucleotide assay method
11/16/1999US5985544 Primers and probes for the detection of HIV
11/16/1999US5985541 Purified polypeptide; quantitative analysis
11/16/1999US5985540 High specificity homocysteine assays for biological samples
11/16/1999US5985351 Genetic engineering cassette of nucleic acid encoding wheat glutenin polypeptide; gene expression
11/16/1999US5985327 Solid medium and method for DNA storage
11/16/1999US5985288 Outer membrane protein P1 and peptides of Haemophilus influenzae type B
11/16/1999US5985287 Compounds and methods for treatment and diagnosis of mycobacterial infections
11/16/1999US5985286 Adenyl cyclase-hemolysin (ac-hly) protein,
11/16/1999US5985285 Vaccines for plague
11/16/1999US5985283 Adenovirus E1A-Associated protein BS69, inhibitor of E1A-transactivation
11/16/1999US5985281 Antibody directed enzyme prodrug therapy (adept) using a non-naturally occuring mutant form of a host enzyme, especially a mutant form of ribonuclease.
11/16/1999US5985280 Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor
1 ... 3326 3327 3328 3329 3330 3331 3332 3333 3334 3335 3336 3337 3338 3339 3340 3341 3342 3343 3344 3345 3346 ... 4023